Φορτώνει......
Early phase clinical trials—are dose expansion cohorts needed?
Dose-expansion cohorts (DECs) enable investigators to identify potentially effective drugs, for specific patient populations, in a single trial by assessing antitumour activity as early as possible. We discuss how the objectives, design and interpretation of DEC have evolved, and how DECs are changi...
Αποθηκεύτηκε σε:
Τόπος έκδοσης: | Nat Rev Clin Oncol |
---|---|
Κύριοι συγγραφείς: | , |
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
2015
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758199/ https://ncbi.nlm.nih.gov/pubmed/26441082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2015.174 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|